Related Experiment Video
Updated: Jul 13, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis
Shogo Matsuda1, Katsumasa Oe1, Takuya Kotani1
1Department of Internal Medicine IV, Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
Abstract:
This study aimed to evaluate the risk factors for end-stage renal disease (ESRD) in microscopic polyangiitis (MPA). In total, 74 patients with MPA were enrolled, and we compared the baseline clinical characteristics and disease activity between MPA patients who have progressed to ESRD and those without ESRD to select predictive factors for ESRD. Out of 74 patients, 12 patients (16.2%) had ESRD during follow-up. Serum C4 levels were significantly higher in MPA patients who have progressed to ESRD than in those without ESRD (p = 0.009). Multivariate analyses revealed that high serum creatinine levels (odds ratio (OR) 4.4, 95% confidence interval (CI) 1.25-15.5) and high serum C4 levels (OR 1.24, 95% CI 1.03-1.49) were risk factors for ESRD. Using receiver operating characteristic analysis, the cut-off value for initial serum C4 levels and serum creatinine levels were 29.6 mg/dL and 3.54 mg/dL, respectively. Patients with MPA with a greater number of risk factors (serum C4 levels > 29.6 mg/dL and serum creatinine levels > 3.54 mg/dL) had a higher ESRD progression rate. Serum C4 levels were significantly positively correlated with serum creatinine levels and kidney Birmingham vasculitis activity score (p = 0.02 and 0.04, respectively). These results suggest that serum C4 levels are useful tools for assessing renal disease activity and prognosis in MPA.
Insights
High serum creatinine and C4 levels are key risk factors for end-stage renal disease (ESRD) in microscopic polyangiitis (MPA). Monitoring these markers aids in predicting ESRD progression in MPA patients.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Microscopic polyangiitis (MPA) is a systemic vasculitis that can affect the kidneys.
- End-stage renal disease (ESRD) is a severe complication of MPA, necessitating identification of predictive factors.
Purpose of the Study:
- To identify risk factors for the progression to ESRD in patients with microscopic polyangiitis.
- To evaluate the utility of serum C4 and creatinine levels in predicting renal outcomes in MPA.
Main Methods:
- Retrospective analysis of 74 MPA patients comparing those with and without ESRD.
- Multivariate logistic regression and receiver operating characteristic (ROC) analyses to identify predictive factors and cut-off values.
Main Results:
- 16.2% of MPA patients developed ESRD during follow-up.
- Elevated serum C4 (p=0.009) and serum creatinine levels were significantly associated with ESRD.
- High serum creatinine (OR 4.4) and serum C4 (OR 1.24) were identified as independent risk factors for ESRD.
Conclusions:
- Serum C4 and creatinine levels are valuable predictors of ESRD in MPA patients.
- Specific cut-off values (C4: 29.6 mg/dL, Creatinine: 3.54 mg/dL) can help stratify ESRD risk.
- Serum C4 levels correlate with renal disease activity and prognosis in MPA.
More Related Videos
Related Concept Videos
Serum Studies: Renal Function Tests
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Nephrotic Syndrome II : Assessment and Medical Management
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction

